The University of Southampton
University of Southampton Institutional Repository

Cost-effectiveness of balloon kyphoplasty in patients with symptomatic vertebral compression fractures in a UK setting

Cost-effectiveness of balloon kyphoplasty in patients with symptomatic vertebral compression fractures in a UK setting
Cost-effectiveness of balloon kyphoplasty in patients with symptomatic vertebral compression fractures in a UK setting
Summary: Balloon kyphoplasty (BKP) is a procedure used to treat vertebral compression fractures (VCFs). We developed a cost-effectiveness model to evaluate BKP in United Kingsdom patients with hospitalised VCFs and estimated the cost-effectiveness of BKP compared to non-surgical management. The results indicate that BKP provides a cost-effective alternative for treating these patients.

Introduction: VCFs of osteoporotic patients are associated with chronic pain, a reduction in health-related quality of life (QoL) and high healthcare costs. BKP is a minimally invasive procedure that has resulted in pain relief, vertebral body height-restoration, decreased kyphosis and improved physical functioning in patients with symptomatic VCFs. BKP was shown to improve health-related QoL in a 12-month interim analysis of a randomised phase-III trial.

Methods: The objectives of this study were to develop a Markov cost-effectiveness model to evaluate BKP in patients with painful hospitalised VCFs and to estimate the cost-effectiveness of BKP compared with non-surgical management in a UK setting. It was assumed that QoL-benefits found at 12 months linearly approached zero during another 2 years, and that patients receiving BKP warranted six fewer hospital bed days compared with patients given non-surgical management.

Results: The procedure was associated with quality-adjusted life-years (QALY)-gains of 0.17 and cost/QALY-gains at pound8,800. The results were sensitive to assumptions about avoided length of hospital-stay and persistence of kyphoplasty-related QoL-benefits.

Conclusion: In conclusion, the results indicate that BKP provides a cost-effective alternative for treating patients with hospitalised VCFs in a UK-setting.

hta, markov, osteoporosis, qaly, uk
0937-941X
Strom, O.
b35a1ed8-a739-44d7-a058-a55e703fcdba
Leonard, C.
6d10e9bd-7ddc-4e4e-95d1-40864d12574a
Marsh, D.
7c06e90c-dfd8-4717-8907-b304f8773d36
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Strom, O.
b35a1ed8-a739-44d7-a058-a55e703fcdba
Leonard, C.
6d10e9bd-7ddc-4e4e-95d1-40864d12574a
Marsh, D.
7c06e90c-dfd8-4717-8907-b304f8773d36
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6

Strom, O., Leonard, C., Marsh, D. and Cooper, C. (2009) Cost-effectiveness of balloon kyphoplasty in patients with symptomatic vertebral compression fractures in a UK setting. Osteoporosis International. (doi:10.1007/s00198-009-1096-6).

Record type: Article

Abstract

Summary: Balloon kyphoplasty (BKP) is a procedure used to treat vertebral compression fractures (VCFs). We developed a cost-effectiveness model to evaluate BKP in United Kingsdom patients with hospitalised VCFs and estimated the cost-effectiveness of BKP compared to non-surgical management. The results indicate that BKP provides a cost-effective alternative for treating these patients.

Introduction: VCFs of osteoporotic patients are associated with chronic pain, a reduction in health-related quality of life (QoL) and high healthcare costs. BKP is a minimally invasive procedure that has resulted in pain relief, vertebral body height-restoration, decreased kyphosis and improved physical functioning in patients with symptomatic VCFs. BKP was shown to improve health-related QoL in a 12-month interim analysis of a randomised phase-III trial.

Methods: The objectives of this study were to develop a Markov cost-effectiveness model to evaluate BKP in patients with painful hospitalised VCFs and to estimate the cost-effectiveness of BKP compared with non-surgical management in a UK setting. It was assumed that QoL-benefits found at 12 months linearly approached zero during another 2 years, and that patients receiving BKP warranted six fewer hospital bed days compared with patients given non-surgical management.

Results: The procedure was associated with quality-adjusted life-years (QALY)-gains of 0.17 and cost/QALY-gains at pound8,800. The results were sensitive to assumptions about avoided length of hospital-stay and persistence of kyphoplasty-related QoL-benefits.

Conclusion: In conclusion, the results indicate that BKP provides a cost-effective alternative for treating patients with hospitalised VCFs in a UK-setting.

This record has no associated files available for download.

More information

Published date: 19 November 2009
Keywords: hta, markov, osteoporosis, qaly, uk

Identifiers

Local EPrints ID: 152129
URI: http://eprints.soton.ac.uk/id/eprint/152129
ISSN: 0937-941X
PURE UUID: 73a7989d-365a-47be-839a-ab2eb45c095b
ORCID for C. Cooper: ORCID iD orcid.org/0000-0003-3510-0709

Catalogue record

Date deposited: 13 May 2010 13:38
Last modified: 18 Mar 2024 02:44

Export record

Altmetrics

Contributors

Author: O. Strom
Author: C. Leonard
Author: D. Marsh
Author: C. Cooper ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×